{"pmid":32476643,"title":"Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer?","text":["Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer?","Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer?","Am J Trop Med Hyg","Nachega, Jean B","Leisegang, Rory","Kallay, Oscar","Mills, Edward J","Zumla, Alimuddin","Lester, Richard T","32476643"],"abstract":["Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer?"],"journal":"Am J Trop Med Hyg","authors":["Nachega, Jean B","Leisegang, Rory","Kallay, Oscar","Mills, Edward J","Zumla, Alimuddin","Lester, Richard T"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476643","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.4269/ajtmh.20-0506","topics":["Prevention"],"weight":1,"_version_":1668437834942382080,"score":9.490897,"similar":[{"pmid":32303497,"title":"Chloroquine and COVID-19 - a potential game changer?","text":["Chloroquine and COVID-19 - a potential game changer?","The novel coronavirus SARS-CoV-2, causing the disease COVID-19, first emerged in Wuhan, China in December 2019 and has now spread to 203 countries or territories, infected over 2 million people and caused over 133,000 deaths. There is an urgent need for specific treatments. One potential treatment is chloroquine and its derivatives, including hydroxychloroquine, which have both antiviral and anti-inflammatory effects. These compounds are effective against SARS-CoV-2 in vitro, but in vivo data are lacking. Although some encouraging outcomes have been reported, and these results have been received enthusiastically, we recommend careful and critical evaluation of current evidence only when all methods and data are available for peer review. Chloroquine is safe and cheap. However, further evidence from coordinated multicentre trials is required before it can be confidently said whether it is effective against the current pandemic.","Clin Med (Lond)","Sturrock, Beattie Rh","Chevassut, Timothy Jt","32303497"],"abstract":["The novel coronavirus SARS-CoV-2, causing the disease COVID-19, first emerged in Wuhan, China in December 2019 and has now spread to 203 countries or territories, infected over 2 million people and caused over 133,000 deaths. There is an urgent need for specific treatments. One potential treatment is chloroquine and its derivatives, including hydroxychloroquine, which have both antiviral and anti-inflammatory effects. These compounds are effective against SARS-CoV-2 in vitro, but in vivo data are lacking. Although some encouraging outcomes have been reported, and these results have been received enthusiastically, we recommend careful and critical evaluation of current evidence only when all methods and data are available for peer review. Chloroquine is safe and cheap. However, further evidence from coordinated multicentre trials is required before it can be confidently said whether it is effective against the current pandemic."],"journal":"Clin Med (Lond)","authors":["Sturrock, Beattie Rh","Chevassut, Timothy Jt"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303497","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.7861/clinmed.2020-0129","keywords":["2019-ncov","covid-19","sars-cov-2","chloroquine","coronavirus"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Hydroxychloroquine","Chloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138491040301057,"score":106.682594},{"pmid":32352927,"title":"Problematic online gaming and the COVID-19 pandemic.","text":["Problematic online gaming and the COVID-19 pandemic.","Stay-at-home mandates and quarantines related to the coronavirus (COVID-19) pandemic have led to greatly increased participation in online gaming. Initiatives such as #PlayApartTogether that promote gaming for socializing and stress reduction may achieve positive outcomes. Although gaming can be a healthy coping strategy for the majority, it can also pose risks to some vulnerable individuals. Protracted periods of social isolation and technology-based activity pose the danger of solidifying unhealthy lifestyle patterns, leading to difficulties to readaptation when the COVID-19 crisis has passed. Balanced and effective approaches to gaming during the COVID-19 pandemic are needed to support physical and psychological wellbeing.","J Behav Addict","King, Daniel L","Delfabbro, Paul H","Billieux, Joel","Potenza, Marc N","32352927"],"abstract":["Stay-at-home mandates and quarantines related to the coronavirus (COVID-19) pandemic have led to greatly increased participation in online gaming. Initiatives such as #PlayApartTogether that promote gaming for socializing and stress reduction may achieve positive outcomes. Although gaming can be a healthy coping strategy for the majority, it can also pose risks to some vulnerable individuals. Protracted periods of social isolation and technology-based activity pose the danger of solidifying unhealthy lifestyle patterns, leading to difficulties to readaptation when the COVID-19 crisis has passed. Balanced and effective approaches to gaming during the COVID-19 pandemic are needed to support physical and psychological wellbeing."],"journal":"J Behav Addict","authors":["King, Daniel L","Delfabbro, Paul H","Billieux, Joel","Potenza, Marc N"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352927","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1556/2006.2020.00016","keywords":["covid-19","addiction","coronavirus","gaming disorder","pandemic","screen time"],"topics":["Prevention"],"weight":1,"_version_":1666138495637258243,"score":102.657974},{"pmid":32372787,"pmcid":"PMC7194701","title":"Home testing is no quick fix.","text":["Home testing is no quick fix.","UK prime minister Boris Johnson says antibody tests for covid-19 are a game changer, but they may not do much in the short term, argues Michael Le Page.","New Sci","Le Page, Michael","32372787"],"abstract":["UK prime minister Boris Johnson says antibody tests for covid-19 are a game changer, but they may not do much in the short term, argues Michael Le Page."],"journal":"New Sci","authors":["Le Page, Michael"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32372787","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/S0262-4079(20)30662-X","locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["General Info"],"weight":1,"_version_":1666138496427884547,"score":101.5776},{"pmid":32420935,"title":"WHO International Health Regulations (IHR) vs COVID-19 Uncertainty.","text":["WHO International Health Regulations (IHR) vs COVID-19 Uncertainty.","One of WHO primary function is to control and monitor internationally the spread of infectious diseases of the common killers. After SARS-COV, the International Health Regulations (IHR) was adopted in 2005 by all 194 member states to set up national preparedness for an efficient \"early alert and response system\". COVID-19 is a novel virus with an unpredictable course and many uncertainties about its biological, clinical and epidemiological characteristics. COVID-19 is a game changer and calls for a revision of IHR as well as a more biological, clinical and community-cantered preparedness strategy.","Acta Biomed","Stuckelberger, Astrid","Urbina, Manuel","32420935"],"abstract":["One of WHO primary function is to control and monitor internationally the spread of infectious diseases of the common killers. After SARS-COV, the International Health Regulations (IHR) was adopted in 2005 by all 194 member states to set up national preparedness for an efficient \"early alert and response system\". COVID-19 is a novel virus with an unpredictable course and many uncertainties about its biological, clinical and epidemiological characteristics. COVID-19 is a game changer and calls for a revision of IHR as well as a more biological, clinical and community-cantered preparedness strategy."],"journal":"Acta Biomed","authors":["Stuckelberger, Astrid","Urbina, Manuel"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420935","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.23750/abm.v91i2.9626","topics":["Prevention"],"weight":1,"_version_":1667254896724803585,"score":100.78559},{"pmid":32392431,"title":"Role of Non-Profit Organization During COVID-19 for Diabetes Care: Healthcare Inequities and Role of Virtual Specialty Clinic.","text":["Role of Non-Profit Organization During COVID-19 for Diabetes Care: Healthcare Inequities and Role of Virtual Specialty Clinic.","Today, in the US, we have a health care system designed to treat symptoms, not people - and to do so as cheaply as possible with the dual goals of minimizing costs and preventing hospital visits. We are failing on all fronts. We spend more money on healthcare per capita than our Organization for Economic Co-operation and Development (OECD) peers, and our outcomes are mediocre at best. Medicine is not personal, health care professionals often have their hands tied by payers, and geography has too much influence on the quality of care available. This has to end, especially since we have the technology to create a truly patient-focused, whole-person approach - one that treats physical and mental health equally and meets people where they are in every sense. Telemedicine can level the playing field and enable higher-quality, decentralized care that - when needed - brings specialty care to the masses. Other technologies have an important role, too. For patients with insulin-dependent diabetes (type 1 diabetes), widespread uptake of continuous glucose monitors (CGM) the game-changer we need right now that can facilitate telemedicine to remote places and remove healthcare disparities. Health professionals and patients will both win - and ultimately payers will, too.","Diabetes Technol Ther","Panzirer, David","32392431"],"abstract":["Today, in the US, we have a health care system designed to treat symptoms, not people - and to do so as cheaply as possible with the dual goals of minimizing costs and preventing hospital visits. We are failing on all fronts. We spend more money on healthcare per capita than our Organization for Economic Co-operation and Development (OECD) peers, and our outcomes are mediocre at best. Medicine is not personal, health care professionals often have their hands tied by payers, and geography has too much influence on the quality of care available. This has to end, especially since we have the technology to create a truly patient-focused, whole-person approach - one that treats physical and mental health equally and meets people where they are in every sense. Telemedicine can level the playing field and enable higher-quality, decentralized care that - when needed - brings specialty care to the masses. Other technologies have an important role, too. For patients with insulin-dependent diabetes (type 1 diabetes), widespread uptake of continuous glucose monitors (CGM) the game-changer we need right now that can facilitate telemedicine to remote places and remove healthcare disparities. Health professionals and patients will both win - and ultimately payers will, too."],"journal":"Diabetes Technol Ther","authors":["Panzirer, David"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32392431","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1089/dia.2020.0219","locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666528580256923648,"score":83.97928}]}